Alzheimer’s disease and language impairments: social intervention and medical treatment

References

• OECDDatabase Data: Population Development, Historical Data and Forecast2015 [cited June 9, 2015]. Available from: http://stats.oecd.org/#Accessed April 20, 2015
   Google Scholar
• WHOInternational Classification of Diseases (ICD)1994 [cited June 9, 2015]. Available from: http://www.who.int/classifications/icd/en/Accessed April 20, 2015
   Google Scholar
• Stages of Alzheimer’s. Alzheimer’s Association2015 [cited June 9, 2015]. Available from: http://www.alz.org/alzheimers_disease_stages_of_alzheimers.aspAccessed April 20, 2015
   Google Scholar
• KlímováBMarešováPKučaKAssistive technologies for language disorders in dementia [in review]
   Google Scholar
• SperlingRAAisenPSBeckettLAToward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117328029221514248
   PubMed Web of Science ®Google Scholar
• Alzheimer’s AssociationAlzheimer’s Disease Facts and Figures. Alzheimer’s and Dementia2012 [cited June 9, 2015]. Available from: http://www.alz.org/downloads/Facts_Figures_2012.pdfAccessed April 20, 2015
   Google Scholar
• Dementia of the Alzheimer’s Type – Description of StagesWebsite of Charles F and Joanne Knight Alzheimer’s Disease Research Center (Knight ADRC)Washington University School of Medicine in St LouisMissouri, USA2003 [cited June 9, 2015]. Available from: http://knightadrc.wustl.edu/About_Us/PDFs/Stages_of_AD.pdfAccessed April 20, 2015
   Google Scholar
• National Institute on AgingAlzheimer’s DiseaseUnraveling 2 the MysteryUS2012 [cited Jun 9, 2015]. Available from: https://www.nia.nih.gov/sites/default/files/alzheimers_disease_unraveling_the_mystery.pdfAccessed April 20, 2015
   Google Scholar
• FrederiksCHofmannMTReichardTAdvances in diagnosis and treatment of Alzheimer’s diseaseHosp Physician200254754
   Google Scholar
• MacoirJLaforceRJrMonettaLWilsonMLanguage deficits in major forms of dementia and primary progressive aphasias: an update according to new diagnostic criteriaGeriatr Psychol Neuropsychiatr Vieil201412219920824939407
   PubMed Web of Science ®Google Scholar
• ShivanandPReview on Alzheimer’s disease: its cause, symptoms, and treatment at worldwideInt J Appl Biol Pharm Technol200911112120
   Google Scholar
• EliopoulosCCarsonVBVarcarolisECognitive disordersEvolve Resources for Varcarolis’ Foundations of Psychiatric Mental Health NursingSt Louis, MOSaunders Elsevier2006
   Google Scholar
• PekkalaSSemantic Fluency in Mild and Moderate Alzheimer’s DiseaseHelsinkiHakapaino Oy2004
   Google Scholar
• OrangeJBColton-HudsonAEnhancing communication in dementia of the Alzheimer’s typeTop Geriatr Rehabil19981425675
   Web of Science ®Google Scholar
• SavundranayagamMERyanEBAnasAPOrangeJBCommunication and dementia: staff perceptions of conversational strategiesClin Gerontol20073124763
   Web of Science ®Google Scholar
• FerrisSHFarlowMLanguage impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitorsClin Interv Aging201381007101423946647
   PubMed Web of Science ®Google Scholar
• MaresovaPKlimovaBKucaKAlzheimer’s disease: cost cuts call for novel drugs development and national strategyCeska A Slovenska Farmacie201564253026084646
   PubMedGoogle Scholar
• ECEuropean Initiative on Alzheimer’s Disease and Other DementiasBrussels2009 [cited June 9, 2015]. Available from: http://ec.europa.eu/health/ph_information/dissemination/documents/com2009_380_en.pdfAccessed April 20, 2015
   Google Scholar
• SavundranayagamMYHummertMLMontgomeryRJInvestigating the effects of communication problems on caregiver burdenJ Gerontol B Psychol Sci Soc Sci2005601S48S5515643047
   PubMed Web of Science ®Google Scholar
• RipichDNFunctional communication with AD patients: a caregiver training programAlzheimer Dis Assoc Disord199483951097999352
   PubMed Web of Science ®Google Scholar
• ManentiRRepettoCBentrovatoSMarconeABatesECappaSFThe effects of ageing and Alzheimer’s disease on semantic and gender primingBrain2004127102299230615306548
   PubMed Web of Science ®Google Scholar
• Tang-WaiDFGrahamNLAssessment of language function in dementiaGeriatr Aging200811103110
   Google Scholar
• AmievaHJacqmin-GaddaHOrgogozoJMThe 9-year cognitive decline before dementia of the Alzheimer type: a prospective population-based studyBrain20051281093110115774508
   PubMed Web of Science ®Google Scholar
• LawsKRDuncanAGaleTM“Normal’ semantic–phonemic fluency discrepancy in Alzheimer’s disease? A meta-analytic studyCortex20104659560119560132
   PubMed Web of Science ®Google Scholar
• SternYAlbertSTangMXTsaiWYRate of memory decline in AD is related to education and occupation: cognitive reserve?Neurology1999531942195710599762
   PubMed Web of Science ®Google Scholar
• FritschTMcClendonMJSmythKAOgrockiPKEffects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementiaInt J Geriatr Psychiatry20021347363
   Google Scholar
• CapitaniELaiaconaMBassoAPhonetically cued word-fluency, gender differences and aging: a reappraisalCortex1998347797839872380
   PubMed Web of Science ®Google Scholar
• ArrighiHMNeumannPJLieberburgIMTownsendRJLethality of Alzheimer disease and its impact on nursing home placementAlzheimer Dis Assoc Disord2010241909519568155
   PubMed Web of Science ®Google Scholar
• DementiaGuide2015 [cited June 9, 2015]. Available from: http://www.dementiaguide.com/symptomlibrary/memorylanguage/language_difficulty/managementstrategies/Accessed April 20, 2015
   Google Scholar
• ZemekFDrtinovaLNepovimovaEOutcomes of Alzheimer’s disease therapy with acetylcholinesterase inhibitors and memantineExpert Opin Drug Saf201413675977424845946
   PubMed Web of Science ®Google Scholar
• NepovimovaEUliassiEKorabecnyJMultitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effectsJ Med Chem201457208576858925259726
   PubMed Web of Science ®Google Scholar
• HilariKNeedleJJHarrisonKLWhat are the important factors in health-related quality of life for people with aphasia? A systematic reviewArch Phys Med Rehabil201293suppl 18695
   PubMed Web of Science ®Google Scholar
• FerrisSIhlRRobertPTreatment effects of memantine on language in moderate to severe Alzheimer’s disease patientsAlzheimers Dement2009536937419751915
   PubMed Web of Science ®Google Scholar
• WinbladBKilanderLErikssonSSevere Alzheimer’s Disease Study GroupDonepezil in patients with severe Alzheimer’s disease: double-blind, parallel-group, placebo-controlled studyLancet200636795161057106516581404
   PubMed Web of Science ®Google Scholar
• BlackSEDoodyRLiHDonepezil preserves cognition and global function in patients with severe Alzheimer diseaseNeurology200769545946917664405
   PubMed Web of Science ®Google Scholar
• CummingsJJonesRWilkinsonDEffect of donepezil on cognition in severe Alzheimer’s disease: a pooled data analysisJ Alzheimers Dis201021384385120634594
   PubMed Web of Science ®Google Scholar
• WinbladBBlackSEHommaADonepezil treatment in severe Alzheimer’s disease: a pooled analysis of three clinical trialsCurr Med Res Opin200925112577258719735164
   PubMed Web of Science ®Google Scholar
• SchwamEXuYCognition and function in Alzheimer’s disease: identifying the transitions from moderate to severe diseaseDement Geriatr Cogn Disord201029430931620395684
   PubMed Web of Science ®Google Scholar
• FerrisSHSchmittFASaxtonJAnalyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer’s diseaseAlzheimers Res Ther2011332221689411
   PubMed Web of Science ®Google Scholar
• FarlowMRCummingsJLOlinJTMengXEffects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer’s diseaseAm J Alzheimers Dis Other Demen201025434735220392862
   PubMed Web of Science ®Google Scholar
• GrossbergGTSchmittFAMengXTekinSOlinJReviews: effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer’s diseaseAm J Alzheimers Dis Other Demen201025862763321131668
   PubMed Web of Science ®Google Scholar
• BurnsABernabeiRBullockRSafety and efficacy of galantamine (Reminyl) in severe Alzheimer’s disease (the SERAD study): a randomised, placebo-controlled, double-blind trialLancet Neurol2009813919042161
   PubMed Web of Science ®Google Scholar
• ClareLWoodsRCognitive rehabilitation in dementiaNeuropsychol Rehabil200111193517
   Web of Science ®Google Scholar
• ZientzJRackleyAChapmanSBEvidence-based practice recommendations for dementia: educating caregivers on Alzheimer’s disease and training communication strategiesJ Med Speech Lang Pathol2007151liiilxiv
   Google Scholar
• Drug Treatment for Alzheimer’s Disease2015 [cited June 9, 2015]. Available from: http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=147Accessed April 20, 2015
   Google Scholar
• Mayo Clinic StaffAlzheimer’s: Drugs Help Manage Symptoms2014 [cited June 9, 2015]. Available from: http://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/a%20lzheimers/art-20048103Accessed April 20, 2015
   Google Scholar
• PopeSKShueVMBeckCWill a healthy lifestyle help prevent Alzheimer’s diseaseAnnu Rev Public Health20032411113212415146
   PubMed Web of Science ®Google Scholar
• KivipeltoMSolomonAAlzheimer’s disease – the ways of preventionJ Nutr Health Aging2007128994
   Web of Science ®Google Scholar
• RadakZHartNSargaLExercise plays a preventive role against Alzheimer’s diseaseJ Alzheimers Dis20102077778320182027
   PubMed Web of Science ®Google Scholar
• RovioSKåreholtIHelkalaELLeisure-time physical activity at midlife and the risk of dementia and Alzheimer’s diseaseLancet Neurol2005470571116239176
   PubMed Web of Science ®Google Scholar
• Joe VergheseMDRichardBLiptonMDLeisure Activities and the risk of dementia in the elderlyN Engl J Med20033482508251612815136
   PubMed Web of Science ®Google Scholar
• CraikFIMBialystockEFreedmanMDelaying the onset of Alzheimer’s disease. Bilingualism as a form of cognitive reserveNeurology201075191726172921060095
   PubMed Web of Science ®Google Scholar
• BialystokECraikFIMLukGBilingualism: consequences for mind and brainTrends Cogn Sci201216424025022464592
   PubMed Web of Science ®Google Scholar
• BialystokECraikFIMFreedmanMBilingualism as a protection against the onset of symptoms of dementiaNeuropsychologia20074545946417125807
   PubMed Web of Science ®Google Scholar
• SoaresFCde OliveiraTCde MacedoLDCANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative studyClin Interv Aging201510374825565785
   PubMedGoogle Scholar
• VestalLSmith-OlindeLHicksGHuttonTHartJJrEfficacy of language assessment in Alzheimer’s disease: comparing in-person examination and telemedicineClin Interv Aging20061446747118046923
   PubMed Web of Science ®Google Scholar
• SköldungerAJohnellKWinbladBWimoAMortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer’s disease – a simulation studyCurr Alzheimer Res20131020721623036018
   PubMed Web of Science ®Google Scholar
• SoukupOJunDZdarova-KarasovaJA resurrection of 7-MEOTA: a comparison with tacrineCurr Alzheimer Res201310889390624093535
   PubMed Web of Science ®Google Scholar